Evaluation of prazosin effects on depressio

Phase 3

Recruiting

• Conditions: Sleep problems in patients with depressive disorder.; Major depressive disorder, single episode

• Registration Number: IRCT20210409050910N1
• Lead Sponsor: Sabzevar University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 May 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

Confirmation of depression disorder by Beck inventory
Confirmation of sleep disorders by Pittsburg sleep quality index.
Failed to respond to other ordinary medication of sleep disorders

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sleep quality of patients with depressive disorder. Timepoint: Weeks 0, 4 and 8 after starting prazosin. Method of measurement: Pittsburgh Sleep Quality Index.